Loading…

Loading grant details…

Active HORIZON European Commission

Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the balance towards NCDs

€7.19M EUR

Funder European Commission
Recipient Organization Medizinische Universitaet Wien
Country Austria
Start Date Jan 01, 2024
End Date Dec 31, 2028
Duration 1,826 days
Number of Grantees 12
Roles Participant; Coordinator; Associated Partner; Third Party
Data Source European Commission
Grant ID 101136582
Grant Description

While it is known that post-COVID-19-condition (PCC) is caused by SARS-CoV-2 infection, for most other immune-related noncommunicable diseases (IR-NCDs), no such infectious disease (ID) triggers have been identified (yet).

Many IDs exist that could potentially cause IR-NCDs, however these microbes have large genomes encoding many antigens possibly associated with IR-NCDs.

Given that it is challenging to measure all these 100,000s of structures in parallel, they represent the dark matter of ID-immune interactions.Furthermore, exposure to an ID alone typically does not trigger development of an IR-NCD: For example only a subset of patients infected with SARS-CoV-2 develop PCC.

So, genetic- and environmental aspects also affect the onset of IR-NCDs, but the exact factors are unknown for most IR-NCDs.Here, we aim to 1.) identify IDs triggering IR-NCDs by screening for antibody responses against 600,000 ID antigens, and 2.) to disentangle environmental and genetic factors affecting the transition from IDs to IR-NCDs.

We will combine novel multi-omics approaches and technologies for personalized genotyping of HLA and adaptive immune receptor genes to deeply profile 6,000 patients of six IR-NCDs (PCC, multiple sclerosis, ME/CFS, rheumatoid arthritis, lupus, IBD) to identify novel biomarkers and disease mechanisms.This project will represent the largest and most deeply profiled systematic study of multiple IR-NCDs with layered datasets allowing for comparative analyses yielding insights into shared mechanisms and potential differences in the role of IDs between IR-NCDs.

Building on associations identified from population scale and clinical cohorts, we will demonstrate causality in gnotobiotic mouse models, and leverage machine learning (ML) algorithms to predict disease progression and response to treatment.

The combination of novel assays with ML represents a broadly applicable pipeline that can be used for studying the interplay of any other IDs/ IR-NCDs.

All Grantees

Academisch Ziekenhuis Leiden; Medizinische Universitaet Wien; Universitat Basel; Universitatsklinikum Schleswig-Holstein; Assistance Publique Hopitaux de Paris; Academisch Ziekenhuis Groningen; Christian-Albrechts-Universitaet Zu Kiel; Eutema Research Services Gmbh; Hun-Ren Szegedi Biologiai Kutatokozpont; Karolinska Institutet; Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca; Sorbonne Universite

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant